FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025389621> ?p ?o ?g. }

• W2025389621 endingPage "886" @default.
• W2025389621 startingPage "875" @default.
• W2025389621 abstract "Summary Bortezomib is the first approved member of a new class of anti‐myeloma agents, the proteasome inhibitors. Further proteasome inhibitors are needed to optimise this promising treatment option. S‐2209 [1‐[1‐{1‐[(2,4‐Dioxo‐imidazolidin‐1‐ylimino)‐methyl]‐2‐phenyl‐ethylcarbamoyl}‐2‐(1H‐indol‐3‐yl)‐ethylcarbamoyl]‐2‐(1H‐indol)] inhibits the chymotryptic activity of the human 20S proteasome (half maximal effective concentration, IC 50 ∼220 nmol/l) which was determined by a proteasome inhibition assay. A nuclear factor κB inhibition assay revealed a half maximal effective concentration (EC 50 ) of 0·9 μmol/l. The WST‐1 growth assay showed inhibition of cell growth of all tested multiple myeloma (MM) cell lines with an IC 50 between 100 nmol/l and 600 nmol/l. Strong induction of apoptosis was seen in MM cells at nanomolar concentrations (IC 50 ∼300 nm) as well as in primary myeloma cells. No induction of apoptosis was detected in peripheral blood mononuclear cells from healthy humans. Upregulation of p53, activation of JNK protein, and downregulation of Mcl‐1 was revealed. Despite the administration of 15 mg S‐2209/kg/d in wistar rats, no toxicity with respect to body weight, hepatic enzymes, creatinine or haemoglobin was seen. Proteasome inhibition in white blood cells isolated from the treated rats was higher in the S‐2209 treated animals in comparison with the control animals treated with 0·1 mg/kg/d bortezomib. S‐2209 is active in myeloma cells and shows a favourable toxicity profile in first in‐vivo studies. S‐2209 is a promising agent for further clinical development." @default.
• W2025389621 created "2016-06-24" @default.
• W2025389621 creator A5001664010 @default.
• W2025389621 creator A5015779561 @default.
• W2025389621 creator A5017533371 @default.
• W2025389621 creator A5020263217 @default.
• W2025389621 creator A5047054222 @default.
• W2025389621 creator A5052738316 @default.
• W2025389621 creator A5062995678 @default.
• W2025389621 creator A5080040120 @default.
• W2025389621 creator A5082625244 @default.
• W2025389621 date "2009-02-19" @default.
• W2025389621 modified "2023-10-17" @default.
• W2025389621 title "The peptide‐semicarbazone S‐2209, a representative of a new class of proteasome inhibitors, induces apoptosis and cell growth arrest in multiple myeloma cells" @default.
• W2025389621 cites W1949358987 @default.
• W2025389621 cites W1963899781 @default.
• W2025389621 cites W1963909872 @default.
• W2025389621 cites W1977348505 @default.
• W2025389621 cites W1991400488 @default.
• W2025389621 cites W1992459906 @default.
• W2025389621 cites W1992778132 @default.
• W2025389621 cites W2021457628 @default.
• W2025389621 cites W2029276835 @default.
• W2025389621 cites W2029561750 @default.
• W2025389621 cites W2036770241 @default.
• W2025389621 cites W2043049816 @default.
• W2025389621 cites W2055878807 @default.
• W2025389621 cites W2066363570 @default.
• W2025389621 cites W2068696470 @default.
• W2025389621 cites W2072950603 @default.
• W2025389621 cites W2073277210 @default.
• W2025389621 cites W2078302713 @default.
• W2025389621 cites W2085868508 @default.
• W2025389621 cites W2088633231 @default.
• W2025389621 cites W2092537575 @default.
• W2025389621 cites W2099110265 @default.
• W2025389621 cites W2100890240 @default.
• W2025389621 cites W2102591890 @default.
• W2025389621 cites W2104238785 @default.
• W2025389621 cites W2119807130 @default.
• W2025389621 cites W2124560610 @default.
• W2025389621 cites W2132570074 @default.
• W2025389621 cites W2138758351 @default.
• W2025389621 cites W2154021003 @default.
• W2025389621 cites W2156748957 @default.
• W2025389621 cites W2166761147 @default.
• W2025389621 cites W2170939558 @default.
• W2025389621 cites W2316160054 @default.
• W2025389621 cites W2419154990 @default.
• W2025389621 cites W3145716452 @default.
• W2025389621 cites W4236730981 @default.
• W2025389621 cites W4237181574 @default.
• W2025389621 cites W4241442958 @default.
• W2025389621 cites W4245266060 @default.
• W2025389621 cites W4376542883 @default.
• W2025389621 cites W93939081 @default.
• W2025389621 doi "https://doi.org/10.1111/j.1365-2141.2008.07570.x" @default.
• W2025389621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19170678" @default.
• W2025389621 hasPublicationYear "2009" @default.
• W2025389621 type Work @default.
• W2025389621 sameAs 2025389621 @default.
• W2025389621 citedByCount "13" @default.
• W2025389621 countsByYear W20253896212012 @default.
• W2025389621 countsByYear W20253896212013 @default.
• W2025389621 countsByYear W20253896212021 @default.
• W2025389621 crossrefType "journal-article" @default.
• W2025389621 hasAuthorship W2025389621A5001664010 @default.
• W2025389621 hasAuthorship W2025389621A5015779561 @default.
• W2025389621 hasAuthorship W2025389621A5017533371 @default.
• W2025389621 hasAuthorship W2025389621A5020263217 @default.
• W2025389621 hasAuthorship W2025389621A5047054222 @default.
• W2025389621 hasAuthorship W2025389621A5052738316 @default.
• W2025389621 hasAuthorship W2025389621A5062995678 @default.
• W2025389621 hasAuthorship W2025389621A5080040120 @default.
• W2025389621 hasAuthorship W2025389621A5082625244 @default.
• W2025389621 hasBestOaLocation W20253896211 @default.
• W2025389621 hasConcept C104317684 @default.
• W2025389621 hasConcept C127561419 @default.
• W2025389621 hasConcept C137061746 @default.
• W2025389621 hasConcept C178790620 @default.
• W2025389621 hasConcept C185592680 @default.
• W2025389621 hasConcept C190283241 @default.
• W2025389621 hasConcept C202751555 @default.
• W2025389621 hasConcept C203014093 @default.
• W2025389621 hasConcept C27740335 @default.
• W2025389621 hasConcept C2776364478 @default.
• W2025389621 hasConcept C2777478702 @default.
• W2025389621 hasConcept C2778367456 @default.
• W2025389621 hasConcept C29730261 @default.
• W2025389621 hasConcept C55493867 @default.
• W2025389621 hasConcept C62112901 @default.
• W2025389621 hasConcept C86803240 @default.
• W2025389621 hasConcept C98274493 @default.
• W2025389621 hasConceptScore W2025389621C104317684 @default.
• W2025389621 hasConceptScore W2025389621C127561419 @default.
• W2025389621 hasConceptScore W2025389621C137061746 @default.
• W2025389621 hasConceptScore W2025389621C178790620 @default.
• W2025389621 hasConceptScore W2025389621C185592680 @default.

• next